UNM scientists have developed a promising tau-targeting vaccine for Alzheimer’s, showing strong immune responses in animals ...

An unusual partnership between a vacuum maker, a race car legend, and the University of Edinburgh is leading to advances in understanding dementia. Their new study using living tissue has revealed the ...

An increase in physical activity between the ages of 45 and 65 could help prevent Alzheimer's disease, while inactivity may be detrimental to brain health.

Scientists using living human brain tissue have shown for the first time how a toxic form of a protein linked to Alzheimer's ...

Medications like donanemab (Kisunla) and lecanemab (Leqembi) target amyloid plaques that build up in the brain due to ...

A report from the Alzheimer’s Association says new treatments and blood tests could change how doctors detect and treat the ...

A new fluid biomarker for Parkinson’s disease (PD) was developed, offering a high-accuracy biological classification, ...

A team of scientists including UCL researchers has tested four anti-amyloid Alzheimer's therapeutics to find out how the drugs bind to toxic amyloid beta protein to tackle the disease.

The a-secretase cleavage site lies within the amyloid-beta peptide associated with Alzheimer plaques. Therefore, an increase in asecretase activity has been found to be associated with a decrease ...

At the 2025 International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (ADPD), Promis Neurosciences Inc. presented the rational design of an Alzheimer’s ...

Background: Considering the complex pathophysiological mechanisms behind Alzheimer’s disease (AD), a few drugs ... at 37°C before the absorbance at 412 nm was detected using an ELISA reader. Lastly, ...